1082 related articles for article (PubMed ID: 33597531)
1. Innate cell profiles during the acute and convalescent phase of SARS-CoV-2 infection in children.
Neeland MR; Bannister S; Clifford V; Dohle K; Mulholland K; Sutton P; Curtis N; Steer AC; Burgner DP; Crawford NW; Tosif S; Saffery R
Nat Commun; 2021 Feb; 12(1):1084. PubMed ID: 33597531
[TBL] [Abstract][Full Text] [Related]
2. IL-33 expression in response to SARS-CoV-2 correlates with seropositivity in COVID-19 convalescent individuals.
Stanczak MA; Sanin DE; Apostolova P; Nerz G; Lampaki D; Hofmann M; Steinmann D; Krohn-Grimberghe M; Thimme R; Mittler G; Waller CF; Pearce EJ; Pearce EL
Nat Commun; 2021 Apr; 12(1):2133. PubMed ID: 33837219
[TBL] [Abstract][Full Text] [Related]
3. Long-term coexistence of SARS-CoV-2 with antibody response in COVID-19 patients.
Wang B; Wang L; Kong X; Geng J; Xiao D; Ma C; Jiang XM; Wang PH
J Med Virol; 2020 Sep; 92(9):1684-1689. PubMed ID: 32343415
[TBL] [Abstract][Full Text] [Related]
4. Children and Adults in a Household Cohort Study Have Robust Longitudinal Immune Responses Following SARS-CoV-2 Infection or Exposure.
Neeland MR; Bannister S; Clifford V; Nguyen J; Dohle K; Overmars I; Toh ZQ; Anderson J; Donato CM; Sarkar S; Do LAH; McCafferty C; Licciardi PV; Ignjatovic V; Monagle P; Bines JE; Mulholland K; Curtis N; McNab S; Steer AC; Burgner DP; Saffery R; Tosif S; Crawford NW
Front Immunol; 2021; 12():741639. PubMed ID: 34721408
[TBL] [Abstract][Full Text] [Related]
5. Robust innate responses to SARS-CoV-2 in children resolve faster than in adults without compromising adaptive immunity.
Vono M; Huttner A; Lemeille S; Martinez-Murillo P; Meyer B; Baggio S; Sharma S; Thiriard A; Marchant A; Godeke GJ; Reusken C; Alvarez C; Perez-Rodriguez F; Eckerle I; Kaiser L; Loevy N; Eberhardt CS; Blanchard-Rohner G; Siegrist CA; Didierlaurent AM
Cell Rep; 2021 Oct; 37(1):109773. PubMed ID: 34587479
[TBL] [Abstract][Full Text] [Related]
6. Dynamic and features of SARS-CoV-2 infection in Gabon.
Mveang Nzoghe A; Padzys GS; Maloupazoa Siawaya AC; Kandet Yattara M; Leboueny M; Avome Houechenou RM; Bongho EC; Mba-Mezeme C; Mvoundza Ndjindji O; Biteghe-Bi-Essone JC; Boulende A; Essone PN; Ndong Sima CAA; Minkobame U; Zang Eyi C; Ndeboko B; Voloc A; Meye JF; Ategbo S; Djoba Siawaya JF
Sci Rep; 2021 May; 11(1):9672. PubMed ID: 33958601
[TBL] [Abstract][Full Text] [Related]
7. Pre-activated antiviral innate immunity in the upper airways controls early SARS-CoV-2 infection in children.
Loske J; Röhmel J; Lukassen S; Stricker S; Magalhães VG; Liebig J; Chua RL; Thürmann L; Messingschlager M; Seegebarth A; Timmermann B; Klages S; Ralser M; Sawitzki B; Sander LE; Corman VM; Conrad C; Laudi S; Binder M; Trump S; Eils R; Mall MA; Lehmann I
Nat Biotechnol; 2022 Mar; 40(3):319-324. PubMed ID: 34408314
[TBL] [Abstract][Full Text] [Related]
8. Mild Cytokine Elevation, Moderate CD4
Jia R; Wang X; Liu P; Liang X; Ge Y; Tian H; Chang H; Zhou H; Zeng M; Xu J
Virol Sin; 2020 Dec; 35(6):734-743. PubMed ID: 32699972
[TBL] [Abstract][Full Text] [Related]
9. Different Innate and Adaptive Immune Responses to SARS-CoV-2 Infection of Asymptomatic, Mild, and Severe Cases.
Carsetti R; Zaffina S; Piano Mortari E; Terreri S; Corrente F; Capponi C; Palomba P; Mirabella M; Cascioli S; Palange P; Cuccaro I; Milito C; Zumla A; Maeurer M; Camisa V; Vinci MR; Santoro A; Cimini E; Marchioni L; Nicastri E; Palmieri F; Agrati C; Ippolito G; Porzio O; Concato C; Onetti Muda A; Raponi M; Quintarelli C; Quinti I; Locatelli F
Front Immunol; 2020; 11():610300. PubMed ID: 33391280
[TBL] [Abstract][Full Text] [Related]
10. Quantitative SARS-CoV-2 Serology in Children With Multisystem Inflammatory Syndrome (MIS-C).
Rostad CA; Chahroudi A; Mantus G; Lapp SA; Teherani M; Macoy L; Tarquinio KM; Basu RK; Kao C; Linam WM; Zimmerman MG; Shi PY; Menachery VD; Oster ME; Edupuganti S; Anderson EJ; Suthar MS; Wrammert J; Jaggi P
Pediatrics; 2020 Dec; 146(6):. PubMed ID: 32879033
[TBL] [Abstract][Full Text] [Related]
11. Cellular Immunity in COVID-19 Convalescents with PCR-Confirmed Infection but with Undetectable SARS-CoV-2-Specific IgG.
Schwarzkopf S; Krawczyk A; Knop D; Klump H; Heinold A; Heinemann FM; Thümmler L; Temme C; Breyer M; Witzke O; Dittmer U; Lenz V; Horn PA; Lindemann M
Emerg Infect Dis; 2021 Jan; 27(1):. PubMed ID: 33058753
[TBL] [Abstract][Full Text] [Related]
12. Long-Term Humoral Immune Response in Persons with Asymptomatic or Mild SARS-CoV-2 Infection, Vietnam.
Mai HK; Trieu NB; Long TH; Thanh HT; Luong ND; Huy LX; Nguyet LA; Man DNH; Anderson DE; Thanh TT; Chau NVV; Thwaites G; Wang LF; Van Tan L; Hung DT
Emerg Infect Dis; 2021 Feb; 27(2):663-666. PubMed ID: 33496647
[TBL] [Abstract][Full Text] [Related]
13. Insights from Patterns of SARS-CoV-2 Immunoglobulin G Serology Test Results from a National Clinical Laboratory, United States, March-July 2020.
Kaufman HW; Chen Z; Meyer WA; Wohlgemuth JG
Popul Health Manag; 2021 Feb; 24(S1):S35-S42. PubMed ID: 33216694
[TBL] [Abstract][Full Text] [Related]
14. Immunological imprint of COVID-19 on human peripheral blood leukocyte populations.
Kratzer B; Trapin D; Ettel P; Körmöczi U; Rottal A; Tuppy F; Feichter M; Gattinger P; Borochova K; Dorofeeva Y; Tulaeva I; Weber M; Grabmeier-Pfistershammer K; Tauber PA; Gerdov M; Mühl B; Perkmann T; Fae I; Wenda S; Führer H; Henning R; Valenta R; Pickl WF
Allergy; 2021 Mar; 76(3):751-765. PubMed ID: 33128792
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of SARS-CoV-2-Antibodies in Danish Children and Adults.
Rytter MJH; Nygaard U; Mandic IN; Glenthøj JP; Schmidt LS; Cortes D; Smith B; Zaharov T; Søndergaard MJ; Lawaetz MC; Saekmose S; Jensen LH; Schmiegelow K; Kristensen K
Pediatr Infect Dis J; 2021 Apr; 40(4):e157-e159. PubMed ID: 33427800
[TBL] [Abstract][Full Text] [Related]
16. Dynamic changes in anti-SARS-CoV-2 antibodies during SARS-CoV-2 infection and recovery from COVID-19.
Li K; Huang B; Wu M; Zhong A; Li L; Cai Y; Wang Z; Wu L; Zhu M; Li J; Wang Z; Wu W; Li W; Bosco B; Gan Z; Qiao Q; Wu J; Wang Q; Wang S; Xia X
Nat Commun; 2020 Nov; 11(1):6044. PubMed ID: 33247152
[TBL] [Abstract][Full Text] [Related]
17. Kinetics of Viral Clearance and Antibody Production Across Age Groups in Children with Severe Acute Respiratory Syndrome Coronavirus 2 Infection.
Bahar B; Jacquot C; Mo YD; DeBiasi RL; Campos J; Delaney M
J Pediatr; 2020 Dec; 227():31-37.e1. PubMed ID: 32891640
[TBL] [Abstract][Full Text] [Related]
18. The legacy of maternal SARS-CoV-2 infection on the immunology of the neonate.
Gee S; Chandiramani M; Seow J; Pollock E; Modestini C; Das A; Tree T; Doores KJ; Tribe RM; Gibbons DL
Nat Immunol; 2021 Dec; 22(12):1490-1502. PubMed ID: 34616036
[TBL] [Abstract][Full Text] [Related]
19. Heightened Circulating Interferon-Inducible Chemokines, and Activated Pro-Cytolytic Th1-Cell Phenotype Features Covid-19 Aggravation in the Second Week of Illness.
Tincati C; Cannizzo ES; Giacomelli M; Badolato R; d'Arminio Monforte A; Marchetti G
Front Immunol; 2020; 11():580987. PubMed ID: 33193384
[TBL] [Abstract][Full Text] [Related]
20. Differences in Clinical Features and Laboratory Results between Adults and Children with SARS-CoV-2 Infection.
Li X; Rong Y; Zhang P; Wang J; Qie L; Rong L; Xu J
Biomed Res Int; 2020; 2020():6342598. PubMed ID: 33294449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
